⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HURA News
TuHURA Biosciences, Inc. Common Stock
Form 8-K
sec.gov
CYDY
HRTX
ANAB
HURA
FBLG
ESPR
Form 8-K
sec.gov
HURA
TuHURA Biosciences Receives New U.S. Patent Broadening Coverage for its VISTA Inhibitor, TBS-2025
prnewswire.com
HURA
TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (DOR) Antibody Drug Conjugate (ADC) Technology
prnewswire.com
HURA
Form 8-K
sec.gov
HURA
Form 8-K
sec.gov
HURA
Form 8-K/A
sec.gov
HURA
Form 8-K
sec.gov
HURA
TuHURA Biosciences Receives FDA "Study May Proceed" Notice and IND Clearance for the Evaluation of its TBS-2025 VISTA-Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood-Related Cancers
prnewswire.com
HURA
TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
prnewswire.com
HURA